Abstract
Introduction
Placental mRNA can now be detected in maternal whole blood, raising the possibility of using maternal blood for noninvasive prenatal diagnosis (NIPD) of trisomy 21. We aimed to identify new mRNA-single nucleotide polymorphism (mRNA-SNP) markers suitable for use in reverse-transcriptase multiplex ligation-dependent probe amplification (RT-MLPA) to develop a more reliable diagnostic method for trisomy 21 in Chinese subjects.
Materials and methods
Using sequencing, we determined the status of SNPs in genes expressed in the placenta and calculated their heterozygote frequencies to determine which loci were suitable for use in RT-MLPA. Cell-free fetal RNA was extracted from peripheral blood samples of 246 women at 12–24 weeks of pregnancy, and the SNP loci selected were analyzed by RT-MLPA, followed by capillary electrophoresis. Karyotype analyses were used to confirm the diagnosis of trisomy 21.
Results
As compared with karyotype analysis, the diagnostic sensitivity and specificity of RT-MLPA were excellent (95 and 100 % in different gestational weeks).
Conclusion
The RT-MLPA technique is a suitable and reliable method for the diagnosis of trisomy 21. Use of RT-MLPA with the SNP markers described here shows good specificity, high sensitivity, and high throughput potential, making this technique suitable for NIPD in clinical practice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Malone FD, Canick JA, Ball RH et al (2005) First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med 353:2001–2011
Wright CF, Burton H (2009) The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update 15:139–151
Mujezinovic F, Alfirevic Z (2007) Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 110:687–694
Chiu RW, Chan KC, Gao Y et al (2008) Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Nat Aca Sci USA 105:20458–20463
Lun FM, Tsui NB, Chan KC et al (2008) Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Nat Aca Sci USA 105:19920–19925
Lo YM, Corbetta N, Chamberlain PF et al (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350:485–487
Farina A, Chan CW, Chiu RW et al (2004) Circulating corticotropin-releasing hormone mRNA in maternal plasma: relationship with gestational age and severity of preeclampsia. Clin Chem 50:1851–1854
Lo YM, Tsui NB, Chiu RW et al (2007) Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 13:218–223
Tsui NB, Chim SS, Chiu RW et al (2004) Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J Med Genet 41:461–467
Schouten JP, McElgunn CJ, Waaijer R et al (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57
Boormans EM, Birnie E, Wildschut HI et al (2008) Multiplex ligation-dependent probe amplification versus karyotyping in prenatal diagnosis: the M.A.K.E. study. BMC Pregnancy Childbirth 8:18
Deng YH, Yin AH, He Q et al (2011) Non-invasive prenatal diagnosis of trisomy 21 by reverse transcriptase multiplex ligation-dependent probe amplification. Clin Chem Lab Med 49:641–646
Diego-Alvarez D, Ramos-Corrales C, Garcia-Hoyos M et al (2006) Double trisomy in spontaneous miscarriages: cytogenetic and molecular approach. Hum Reprod 21:958–966 (Oxford, England)
Hochstenbach R, Meijer J, van de Brug J et al (2005) Rapid detection of chromosomal aneuploidies in uncultured amniocytes by multiplex ligation-dependent probe amplification (MLPA). Prenatal Diag 25:1032–1039
Go AT, Visser A, Mulders MA et al (2007) 44 single-nucleotide polymorphisms expressed by placental RNA: assessment for use in noninvasive prenatal diagnosis of trisomy 21. Clin Chem 53:2223–2224
Liao X, Lochhead P, Nishihara R et al (2012) Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 367:1596–1606
Mavrou A, Kouvidi E, Antsaklis A et al (2007) Identification of nucleated red blood cells in maternal circulation: a second step in screening for fetal aneuploidies and pregnancy complications. Prenatal Diag 27:150–153
Wapner RJ (2005) Invasive prenatal diagnostic techniques. Semin Perinatol 29:401–404
Amor DJ, Neo WT, Waters E et al (2006) Health and developmental outcome of children following prenatal diagnosis of confined placental mosaicism. Prenatal Diag 26:443–448
Eldering E, Spek CA, Aberson HL et al (2003) Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. Nucleic Acids Res 31:e153
Tsui NB, Wong BC, Leung TY et al (2009) Non-invasive prenatal detection of fetal trisomy 18 by RNA-SNP allelic ratio analysis using maternal plasma SERPINB2 mRNA: a feasibility study. Prenatal Diag 29:1031–1037
Acknowledgments
This study was supported by The Medical and Scientific Fund from Guangdong Province (Grant No. B2009076), The Scientific Plan Fund from Guangdong Province (Grant No. 2009B060700107) and The Doctor Development Fund in Guangzhou Medical University (Grant No. L95042).
Conflict of interest
There are no conflicts of interest regarding this paper.
Author information
Authors and Affiliations
Corresponding author
Additional information
P. Li and J. Zhang contributed equally to the study.
Rights and permissions
About this article
Cite this article
Li, Pq., Zhang, J., Fan, Jh. et al. Development of noninvasive prenatal diagnosis of trisomy 21 by RT-MLPA with a new set of SNP markers. Arch Gynecol Obstet 289, 67–73 (2014). https://doi.org/10.1007/s00404-013-2926-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-013-2926-5